Search

Your search keyword '"Cefuroxime blood"' showing total 120 results

Search Constraints

Start Over You searched for: Descriptor "Cefuroxime blood" Remove constraint Descriptor: "Cefuroxime blood"
120 results on '"Cefuroxime blood"'

Search Results

1. The New Delhi metallo-β-lactamase-1 biosensor rapidly and accurately detected antibiotic plasma concentrations in cefuroxime-treated patients.

2. Quantification of cefuroxime and flucloxacillin in synovial tissue and bone using ultra-performance convergence chromatography-tandem mass spectrometry.

Catalog

Books, media, physical & digital resources

3. Halloysite nanotubes-based hybrid silica monolithic spin tip for hydrophilic solid-phase extraction of sulbactam, cefoperazone, and cefuroxime in whole blood.

4. A fast, cost-saving and sensitive method for determination of cefuroxime in plasma by HPLC with ultraviolet detection.

5. Simultaneous quantification of cefuroxime and clindamycin in human lumbar anulus fibrosus, nucleus pulposus and serum via UPLC-MS/MS.

6. Preliminary physiologically based pharmacokinetic modeling of renally cleared drugs in Chinese pregnant women.

7. Population pharmacokinetics of cefuroxime and uptake into hip and spine bone of patients undergoing orthopaedic surgery.

8. Quantification of total and unbound cefuroxime in plasma by ultra-performance liquid chromatography tandem mass spectrometry in a cohort of critically ill patients with hypoalbuminemia and renal failure.

9. Physiologically based pharmacokinetic evaluation of cefuroxime in perioperative antibiotic prophylaxis.

10. Bone, subcutaneous tissue and plasma pharmacokinetics of cefuroxime in total knee replacement patients - a randomized controlled trial comparing continuous and short-term infusion.

11. Preparation and evaluation of cefuroxime axetil gastro-retentive floating drug delivery system via hot melt extrusion technology.

12. Colo-Pro: a pilot randomised controlled trial to compare standard bolus-dosed cefuroxime prophylaxis to bolus-continuous infusion-dosed cefuroxime prophylaxis for the prevention of infections after colorectal surgery.

13. Synthesis and characterization of triazole based supramolecule for interaction with cefuroxime in tap water and blood plasma.

14. Pharmacokinetics of Cefuroxime in Synovial Fluid.

15. Quantification of three beta-lactam antibiotics in breast milk and human plasma by hydrophilic interaction liquid chromatography/positive-ion electrospray ionization mass spectrometry.

16. Clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy.

17. Treatment of cefuroxime-induced neurotoxicity with continuous venovenous haemofiltration.

18. Effects of Implant-Associated Osteomyelitis on Cefuroxime Bone Pharmacokinetics: Assessment in a Porcine Model.

19. Decreased placental and transcellular permeation of cefuroxime in pregnant women with diabetes.

20. Pharmacokinetics of cefuroxime after intravenous, intramuscular, and subcutaneous administration to dogs.

21. Targeting cefuroxime plasma concentrations during coronary artery bypass graft surgery with cardiopulmonary bypass.

22. Continuous versus short-term infusion of cefuroxime: assessment of concept based on plasma, subcutaneous tissue, and bone pharmacokinetics in an animal model.

23. Blood concentrations of cefuroxime in cardiopulmonary bypass surgery.

24. Effects of amlodipine on the oral bioavailability of cephalexin and cefuroxime axetil in healthy volunteers.

25. Influence of cardiopulmonary bypass on cefuroxime plasma concentration and pharmacokinetics in patients undergoing coronary surgery.

26. [Determination of cefuroxime in liver-injured rat plasma by ultra fast liquid chromatography-tandem mass spectrometry via acidified protein precipitation].

27. Saliva and blood concentration of cefuroxime in patients undergoing maxillofacial surgery.

28. A fast, sensitive, and high throughput method for the determination of cefuroxime lysine in dog plasma by UPLC-MS/MS.

29. Bioequivalence and population pharmacokinetic modeling of two forms of antibiotic, cefuroxime lysine and cefuroxime sodium, after intravenous infusion in beagle dogs.

30. Cefuroxime pharmacokinetics in pediatric cardiovascular surgery patients undergoing cardiopulmonary bypass.

32. Liquid chromatography/electrospray tandem mass spectrometry method for the determination of cefuroxime in human plasma: application to a pharmacokinetic study.

33. Penetration of cefuroxime in subcutaneous tissue during coronary artery bypass grafting surgery.

34. Quantification and prediction of skin pharmacokinetics of amoxicillin and cefuroxime.

35. Simultaneous determination of five beta-lactam antibiotics (cefepim, ceftazidim, cefuroxim, meropenem and piperacillin) in human plasma by high-performance liquid chromatography with ultraviolet detection.

36. Effect of severity disease on the pharmacokinetics of cefuroxime in children with multiple organ system failure.

37. Perioperative cefuroxime pharmacokinetics in cardiac surgery.

38. Tissue and plasma concentrations of cephuroxime during cardiac surgery in cardiopulmonary bypass--a microdialysis study.

39. Systemic availability of prophylactic cefuroxime in patients submitted to coronary artery bypass grafting with cardiopulmonary bypass.

40. Bioequivalence evaluation of 2 brands of cefuroxime axetil 250 mg tablets in healthy human volunteers.

41. Determination of cefuroxime in human serum or plasma by liquid chromatography with electrospray tandem mass spectrometry.

43. Evaluation of oral antimicrobial agent levels in tooth extraction sites.

44. Serum concentrations of cefuroxime after continuous infusion in coronary bypass graft patients.

45. Pharmacokinetics and absolute bioavailability of oral cefuroxime axetil in the rat.

46. Simultaneous measurement of cefuroxime in rat blood and brain by microdialysis and microbore liquid chromatography. Application to pharmacokinetics.

47. Detection of borreliacidal antibodies in Lyme borreliosis patient sera containing antimicrobial agents.

48. Comparison of bactericidal activity after multidose administration of clarithromycin, azithromycin, and ceruroxime axetil against Streptococcus pneumoniae.

49. Pharmacokinetics of cefuroxime in healthy volunteers: an update.

50. Measuring antibiotic levels in otitis media.